vTv Therapeutics (VTVT) Interest Expenses (2014 - 2025)

vTv Therapeutics has disclosed Interest Expenses across 11 years of filings, most recently posting $1000.0 for Q4 2025.

• In Q4 2025, Interest Expenses changed N/A year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $6000.0 (down 14.29% YoY), while the FY2025 annual figure was $6000.0, changed N/A from the prior year.
• Interest Expenses came in at $1000.0 for Q4 2025 at vTv Therapeutics, down from $5000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8000.0 in Q3 2022 to a low of $1000.0 in Q1 2022.
• Average Interest Expenses over 4 years is $4600.0, with a median of $5500.0 recorded in 2021.
• Year-over-year, Interest Expenses plunged 97.45% in 2021 and surged 33.33% in 2022.
• Over 4 years, Interest Expenses stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then grew by 16.67% to $7000.0 in 2023, then tumbled by 85.71% to $1000.0 in 2025.
• Per Business Quant data, the three most recent Interest Expenses figures were $1000.0 in Q4 2025, $5000.0 in Q3 2025, and $7000.0 in Q4 2023.